In a previous study of tissue microenvironments, our laboratory identified CD36 repression as a characteristic of the invasive breast cancer (IBC)-associated stroma and the stroma of tissue at high risk for future cancers (1). This evidence concerns the gene CD36 and inflammatory breast carcinoma.